Pricing Log in Create free account
Saturday 17 October 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/Sales of 3.0×. Over the past ten years it has ranged from 2.7× (May 2026) to 7.3× (April 2021); the current reading is higher than 4% of that period. That is above the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.0× (14.97%)
FY2024 3.5× (14.86%)
FY2023 4.2× (9.99%)
FY2022 4.6× (2.90%)
FY2021 4.7× (24.01%)
FY2020 6.2× 33.34%
FY2019 4.7× 28.69%
FY2018 3.6× (16.27%)
FY2017 4.3× 8.74%
FY2016 4.0× (16.60%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.8× (5.43%)
Mar 2026 2.9× (2.32%)
Dec 2025 3.0× (8.60%)
Sep 2025 3.3× 2.73%
42 more quarters

Against its own ten years

Low 2.7× High 7.3×
Ten-year median 4.3×
Current reading's percentile 4

EV/Sales against peers

Company EV/Sales
PHG Koninklijke Philips N.V. compare 1.4×
SNN Smith & Nephew SNATS, Inc. compare 1.5×
GEHC GE HealthCare Technologies Inc. compare 1.9×
ZBH Zimmer Biomet Holdings, Inc. 3.0×
GMED Globus Medical, Inc. compare 3.4×
BIO.B Bio-Rad Laboratories, Inc. compare 3.6×
STE STERIS plc compare 3.8×
DXCM DexCom, Inc. compare 6.6×
PEN Penumbra, Inc. compare 8.0×
Medical Devices industry median 2.2×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ZBH